KARLSON B M, HERLITZ J,PETTERSSON P,et al.One-year prognosis in patients hospitalized with a history of unstable angina pectoris[J]. Clin Cardiol,1993,16(5):397-402.
[3]
PEARCE D C,MCCAW J M,MCVERNON J,et al.Influenza as a trigger for cardiovascular disease: an investigation of serotype, subtype and geographic location[J].Environ Res,2017,15(6):688-696.
GROHSKOPF L A,SOKOLOW L Z,BRODER K R,et al.Preve-ntion and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices-United States, 2017-18 influenza season[J]. MMWR Recomm Rep,2018,67(3):1-20.
[6]
MACLNTYRE C R,MAHIMBO A,MOA A M,et al.Influenza vaccine as a coronary intervention for prevention of myocardial infarction[J].Heart,2016,102(24):1953-1956.
[7]
GROHSKOPF L A,SOKOLOW L Z,FRY A M,et al.Update: ACIP recommendations for the use of quadrivalent live attenuated influenza vaccine (LAIV4) - United States, 2018-19 influenza season[J].MMWR Morb Mortal Wkly Rep,2018,67(22):643-645.
[8]
SMITH S C J R,BENJAMIN E J,BONOW R O,et al.AHA/ACCFsecondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation Endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association[J].J Am Coll Cardiol,2011, 58(23):2432-2446.
GURFINKEL E P,LEON DE LA FUENTE R,MENDIZ O,et al.Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study[J].Eur Heart J,2004,25(1):25-31.
EZRA A A,NANETTE K W,RALPH G B.2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines[J].Circulation,2014,130(25):344-426.
[14]
DARVISHIAN M,VAN DEN HEUVEL E R,BISSIELO A,et al.Effectiveness of seasonal influenza vaccination in community-dwellingelderly people: an individual participant data meta-analysis of test-negative design case-control studies[J].Lancet Respir Med,2017,5(3):200-211.
[15]
MODIN D,JORGENSEN M E,GISLASON G,et al.Influenza vaccine in heart failure[J].Circulation,2019,139(5): 575-586.
[16]
WU H H,CHANG Y Y,KUO S C,et al.Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders:a propensity score-matched follow-up study[J].PLoS One,2019,14(7): e0219172.
[17]
VARDENY O,SWEITZER N K,DETRY M A,et al.Decreased immune responses to influenza vaccination in patients with heart failure[J].J Card Fail,2009,15(4):368-373.
[18]
CHIANG M H,WU H H,SHIH C J,et al.Association between influenza vaccination and reduced risks of major adverse cardiovascular events in elderly patients[J].Am Heart J,2017(193):1-7.
[19]
UDELL J A,ZAWI R,BHATT D L,et al.Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis[J].JAMA,2013,310(16):1711-1720.
[20]
SRIBHUTORN A,PHROMMINTIKUL A,WONGCHAROEN W,et al.The modification effect of influenza vaccine on prognostic indicators for cardiovascular events after acute coronary syndrome: observations from an influenza vaccination trial[J]. Cardiol Res Pract,2016:1-9.
[21]
CISZEWSKI A.Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases[J].Vaccine,2018,36(2):202-206.
LULIANO A D,ROGUSKI K M,CHANG H H,et al.Estimates of global seasonal influenza-associated respiratory mortality:a modelling study[J].The Lancet,2017,391(10127):1-16.